Vertex Pharmaceuticals (VRTX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Vertex Pharmaceuticals (VRTX)

VRTX 441.98

+0.1%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (311)	9/17/1999 12:29:00 AM
From: Miljenko Zuanic	Read Replies (1) of 1169

biz.yahoo.com <<Vertex and Hoechst Marion Roussel began collaborating in 1993 to discover and develop orally available inhibitors of ICE. Their intensive design efforts were based on the three-dimensional atomic structure of ICE, solved by Vertex researchers in 1994. As the result of an extensive, jointly conducted synthesis and research program, HMR 3480/VX-740 was selected as a development candidate in 1996. A Phase I clinical trial of HMR 3480/VX-740, completed by Hoechst Marion Roussel earlier in 1999, showed that the compound was well- tolerated in humans in a range of single doses. Phase II development in at least one additional indication is anticipated to begin in 2000.>> Once-a day dosing, well tolerated, $5 M milestone, .... and stock is moving like a dead cat. :( Wish that I have more money. Anyone have few green's to borrow, for a good advice... (PS:...)? :) Miljenko PS: Or I should recommend LIPO (thanks Peter) after today debacle.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next